A Case Report Secondary Syphilis with Multiple Co-Infections of Human Immunodeficiency Virus (HIV), Tuberculosis (TB), and Oral Candidiasis in a 19-Year-Old Men Who Have Sex with Men (MSM): A Case Report
Background: Syphilis is an infection of the Treponema pallidum bacteria that often occurs along with conditions such as Human Immunodeficiency Virus (HIV) infection, tuberculosis (TB), and oral candidiasis. A weakened immune system affects the complex interactions between these conditions and the clinical presentation as well as the therapeutic management provided to patients. Case: A 19-year-old male with a history of HIV complained of lesions on the skin and mouth. Anamnesis, physical examination, and serological test results establish the diagnosis of secondary syphilis and pulmonary tuberculosis, characterized by a one-month history of phlegm coughing and weight loss, was confirmed via sputum testing. Additionally, oral candidiasis was identified based on clinical examination. Discussion: The patient exhibited complex complications from secondary syphilis, HIV infection, TB, and oral candidiasis. In cases of syphilis with HIV, the appropriate treatment is three doses of Benzathine Penicillin G. Anti-Tuberculosis Drugs administration for TB was adjusted based on HIV status and therapy response, and antifungal fluconazole for oral candidiasis. Conclusions: This case highlights the importance of proper management and close monitoring of patients with multiple infectious conditions, including treatment of syphilis patients that has a higher incidence in men who have MSM, HIV, TB, and oral candidiasis. Timely and appropriate therapy strategies are essential to minimize complications and improve clinical outcomes.
Tuddenham SA, Zenilman JM. Syphilis. In: Kang S, Amagai M, Bruckner AK, Enk AH, Margolis DJ, McMichael AJ, et al, editors. Fitzpatrick’s Dermatology in General Medicine. 9th ed. New York: McGraw Hill Education; 2019.p.3145–72
Ministry of Health the Republic of Indonesia. Indonesia Epidemiological Study 2016 [Internet]. 2017. Available from: http://siha.depkes.go.id
Swinkels HM, Vaillant A a. J, Nguyen AD, Gulick PG. HIV and AIDS. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK534860/.
Çakmak SK, Tamer E, Karadağ AS, Waugh M. Syphilis: A great imitator. Clin Dermatol. 2019;37(3):182-191.
Ministry of Health of The Republic Indonesia. Strategic Planning and Implementation of Health Development. National Action Plan for Collaboration TB-HIV Health of Year 2015-2019. Jakarta; 2015. Available from: https://extranet.who.int/countryplanningcycles/sites/default/files/planning_cycle_repository/indonesia/restra_2015_translated_1.pdf
WHO. Global Tuberculosis Report 2022. Geneva: World Health Organization; 2022. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022.
Naidoo K, Baxter C, Karim SSA. When to start antiretroviral therapy during tuberculosis treatment? Curr Opin Infect Dis. 2012; 27(26):35–42.
Mayer KH, Hamilton CD. Synergistic Pandemics: Confronting the Global HIV and Tuberculosis Epidemics. Clin Infect Dis. 2010; 16(50):S67–70.
WHO. Tuberculosis and HIV. 2018 [cited 2018 Jan 2]. Available from: http://www.who.int/hiv/topics/tb/about_tb/en/.
Millstone M, Selkowe E, Stevens LM, editors. New York. Department of Health and Mental Hygiene. Bureau of Sexually Transmitted Infections., New York City STD Prevention Training Center, Centers for Disease Control and Prevention (US). The Diagnosis, Management and Prevention of Syphilis. NewYork: CDC; 2019.
Sparling PF, Swartz MN, Musher DM, Healy BP. Clinical manifestations of syphilis. In: Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH, editors. Sexually transmitted diseases. 4th ed. New York: Mc Graw-Hill; 2008.p.661-84.
Sanchez MR. Sexually transmitted diseases: syphilis. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick's Dermatology. 9th ed. New York: McGraw-Hill; 2019.p.3145-3172.
Andrade R, Rodriguez-Barradas MC, Yasukawa K, Villarreal E, Ross M, Serpa JA. Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial. Clin Infect Dis. 2017; 14(64):759–64.
Jumpertz M, Guilhaumou R, Million M, Parola P, Lagier JC, Brouqui P, et al. Subcutaneously administered antibiotics: a review. JAC. 2022; 27(78):1–7.
World Health Organization. Who Guidelines for The Treatment of Treponema pallidum (syphilis). World Health Organization; 2016. https://iris.who.int/bitstream/handle/10665/249572/9789241549806-eng.pdf?sequence=1.
Mauceri R, Coppini M, Cascio A, Trizzino M, Crivello V, Florena AM, et al. Oral Secondary Syphilis in an HIV-Positive Transgender Patient: A Case Report and Review of the Literature. J. Dent. 2023;26(11):231.
Liwan MA, Taufik SS, Eka HB, Amin S. Benzathine penicillin G intramuscular succesful treatment of ocular syphilis with human immunodeficiency virus positive: A case report. J Oftalmol. 2020;2(2):15-19.
Ramírez-Amador V, Castillejos-García I, Maldonado-Mendoza J, Saeb-Lima M, Aguilar-León D, Anaya-Saavedra G. Exposing the Great Imitator: Proposal for a Holistic Diagnosis of Oral Secondary Syphilis in People Living with HIV. Head and Neck Pathology. 2022;16(3):773-784.
Suvirya S, Gandhi R, Agarwal J, Patil R. Erythematous candidiasis leading to systemic manifestations of human immunodeficiency virus co-infection with secondary syphilis: A diagnostic and therapeutic dilemma. Eur. J. Dent. 2015;1(09):449–52.
Sharma D, Sarkar D. Pathophysiology of Tuberculosis: An Update Review. PharmaTutor. 2018;2(6):15.
Copyright (c) 2024 Berkala Ilmu Kesehatan Kulit dan Kelamin
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.